Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES1 | P23141 | 4/20 | 1.00 |
| ▸ | DNMT1 | P26358 | 2/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.52 |
| ▸ | CES2 | O00748 | 2/20 | 0.52 |
| ▸ | BCHE | P06276 | 2/20 | 0.52 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.52 |
| ▸ | CASP1 | P29466 | 2/20 | 0.46 |
| ▸ | PABPC1 | P11940 | 2/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | CASP7 | P55210 | 1/20 | 0.46 |
| ▸ | MAOA | P21397 | 4/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.44 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | FYN | P06241 | 1/20 | 0.44 |
| ▸ | ACHE | P22303 | 1/20 | 0.44 |
| ▸ | AHR | P35869 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2156357 | 1.00 | CES1 (1.00) | CES1DNMT1ALDH1A1CES2BCHE | |
| SCHEMBL8758317 | 0.92 | CES1 (0.84) | CES1DNMT1ALDH1A1CES2BCHE | |
| SCHEMBL29773016 | 0.84 | CES1 (0.73) | CES1DNMT1ALDH1A1CES2BCHE | |
| SCHEMBL31619723 | 0.84 | CES1 (0.72) | CES1DNMT1ALDH1A1CES2BCHE | |
| SCHEMBL8545834 | 0.82 | CES1 (0.69) | CES1DNMT1ALDH1A1CES2BCHE | |
| SCHEMBL15243604 | 0.79 | CES1 (0.65) | CES1DNMT1ALDH1A1CES2BCHE | |
| SCHEMBL15243608 | 0.79 | CES1 (0.65) | CES1DNMT1ALDH1A1MCL1CASP1 | |
| SCHEMBL14257654 | 0.79 | CES1 (0.64) | CES1DNMT1ALDH1A1CES2BCHE | |
| SCHEMBL580216 | 0.79 | CES1 (0.65) | CES1DNMT1ALDH1A1CASP1MAOA | |
| SCHEMBL29531588 | 0.79 | CES1 (0.65) | CES1DNMT1ALDH1A1CASP1PABPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 170 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109957050-B | Asymmetric (alpha-diimine) nickel olefin catalyst and preparation method and application thereof | 杭州星庐科技有限公司 | 2022-03-08 | — | — | CN | claimed |
| CN-109957050-A | Asymmetric (alpha-diimine) nickel alkene catalyst and its preparation method and application | 杭州星庐科技有限公司 | 2019-07-02 | — | — | CN | claimed |
| US-7973034-B2 | Ameliorating toxic effects of such as cancer therapy drugs or addictive drug overdose | ST. JUDE CHILDREN'S RESEARCH HOSPITAL (US) | 2011-07-05 | — | — | US | claimed |
| US-5663029-A | DEVELOPMENT OF LATENT IMAGE, TRANSFERRING TO FORM RECORDING SHEETS, COATING A SUBSTRATE USING POLYMERS | XEROX CORPORATION (US) | 1997-09-02 | — | — | US | claimed |
| EP-3596184-B1 | ADHESIVE BONDING COMPOSITION AND ELECTRONIC COMPONENTS PREPARED FROM THE SAME | IMMUNOLIGHT LLC (US) | 2025-11-19 | — | — | EP | disclosed |
| US-20240392220-A1 | BRANDY REPLICAS | AVA FOOD LABS, INC. | 2024-11-28 | — | — | US | disclosed |
| US-12076579-B2 | Energy augmentation structures in adhesive bonding compositions | IMMUNOLIGHT, LLC (US) | 2024-09-03 | — | — | US | disclosed |
| EP-4408967-A1 | BRANDY REPLICAS | AVA FOOD LABS, INC. (US) | 2024-08-07 | — | — | EP | disclosed |
| CN-118339274-A | Brandy replica | 艾娃食品实验室股份有限公司 | 2024-07-12 | — | — | CN | disclosed |
| US-11964166-B2 | Energy augmentation structures, and their use in adhesive bonding | IMMUNOLIGHT, LLC (US) | 2024-04-23 | — | — | US | disclosed |
| US-11901331-B2 | Adhesive bonding composition and electronic components prepared from the same | IMMUNOLIGHT, LLC (US) | 2024-02-13 | — | — | US | disclosed |
| EP-3839572-B1 | ADHESIVE BONDING COMPOSITION AND METHOD OF USE | IMMUNOLIGHT LLC (US) | 2023-10-18 | — | — | EP | disclosed |
| US-6818327-B2 | COLOR PURITY, EFFICIENCY | IDEMITSU KOSAN CO., LTD. (JP) | 2004-11-16 | — | — | US | disclosed |
| US-6815090-B1 | ACENAPTHO(1,2-K)FLUORANTHENE DERIVATIVES; COLOR PURITY, EFFICIENT LIGHT EMISSION, DURABILITY | IDEMITSU KOSAN CO., LTD. (JP) | 2004-11-09 | — | — | US | disclosed |
| US-20040214043-A1 | Organic electroluminescence device | IDEMITSU KOSAN CO., LTD. (JP) | 2004-10-28 | — | — | US | disclosed |
| WO-2003072614-A2 | THIOL COMPOUND, PHOTOPOLYMERIZATION INITIATOR COMPOSITION AND PHOTOSENSITIVE COMPOSITION | SHOWA DENKO K.K. (JP) | 2003-09-04 | — | — | WO | disclosed |
| US-20030054200-A1 | Organic electroluminescence device | IDEMITSU KOSAN CO., LTD. (JP) | 2003-03-20 | — | — | US | disclosed |
| CN-1327468-A | Organic electroluminescent device | IDEMITSU KOSAN CO (JP) | 2001-12-19 | — | — | CN | disclosed |
| EP-1138745-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT | IDEMITSU KOSAN COMPANY LIMITED (JP) | 2001-10-04 | — | — | EP | disclosed |
| US-5547996-A | Method of producing foamed polymer materials | THE CENTER FOR INNOVATIVE TECHNOLOGY (US) | 1996-08-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11964166-B2 | Energy augmentation structures, and their use in adhesive bonding | FN1, ITGAM, ICAM1 | CES1 3999/4885DNMT1 2104/4885ALDH1A1 377/4885 |
| US-12076579-B2 | Energy augmentation structures in adhesive bonding compositions | FN1, ADIPOR1, ICAM1 | CES1 4165/4885DNMT1 2262/4885ALDH1A1 304/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.